Global Antiemetics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
-
294
-
May 2023
-
181
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
MarketResearch.biz, in its upcoming report titled, “Global Antiemetics Market Trends, Applications, Analysis, Growth, and Forecast to 2027”, offers in-depth insights, revenue details, and other vital information regarding the global antiemetics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report also offers insightful and detailed information regarding the various key players operating in the global antiemetics market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global antiemetics market is being segmented on the basis of drug class, application and region. The global antiemetics market is expected to reach at a CAGR of XX.X% during the period 2018 to 2027.
An antiemetic is a drug that helps to prevent vomiting and nausea. Antiemetics are commonly used to treat the side effects of opioid analgesics, general anesthetics, and chemotherapy. Further, vomiting and nausea are the consequences faced by the patients suffering from illness such as dizziness, motion sickness, pregnancy and food poisoning. In case of gastroenteritis, especially if the patient is dehydrated antiemetics may be used. In case of pregnant women, these drugs provide remarkable relief to women who undergo morning sickness, during the early phase of the pregnancy. Moreover, antiemetic drugs are very helpful for women wherein morning sickness lasts for longer period.
Primary factor driving growth of the global antiemetics market is increasing number of cancer patients worldwide. Chemotherapy used for the treatment of cancer pose side effects such as vomiting and nausea which in turn supports the usage of antiemetic drugs. Furthermore, rising number of gastroenteritis patients drives growth of the global antiemetics market.
However lack of suitable animal model that will mimic the human responses to antiemetic therapy restraints the market growth. Antiemetic drugs, that are in clinical phase requires more improvement in clinical trial design for their commercialization purpose.
North America and Europe markets hold comparatively larger share in global antiemetics market due to increasing rate of cancer affected population. Asia Pacific market is the fastest growing segment owing to high incidence rate of gastroenteritis and other diseases with increasing number of cancer population in the region.
Global Antiemetics Market Segmentation:
Global antiemetics market segmentation by drug class:
- 5-HT3 receptor antagonists
- Dopamine antagonists
- NK1 receptor antagonist
- Antihistamines (H1 histamine receptor antagonists)
- Cannabinoids
- Benzodiazepines
- Anticholinergics
- Steroids
- Others
Global antiemetics market segmentation by application:
- Chemotherapy
- Motion sickness
- Gastroenteritis
- General anesthetics
- Opioid analgesics
- Dizziness
- Pregnancy
- Food poisoning
- Emotional stress
- Others
Global antiemetics market segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
-
- GlaxoSmithKline Pharmaceuticals Limited
- Johnson & Johnson
- Sanofi, Merck & Co.,
- Novartis AG
- Bristol-Myers Squibb
- Astellas Pharma, Inc.,
- Eli Lilly and Company
- Abbott, Cipla Ltd.,
- Reddy’s Laboratories Ltd
- Baxter International
- IPCA Labs
Our Clients
View Our Licence Options
